According to the latest annual report to the nation, overall cancer death rates in men and women continue to decline for all racial and ethnic groups in the United States.
National Cancer Institute
In the period 2001-2018, death rates for lung cancer and melanoma decreased significantly, with a significant increase in survival rates for metastatic melanoma.
The report, which appears in JNCI: The Journal of the National Cancer Institute, covers the period before the COVID-19 pandemic and shows good news for 11 of the 19 most common cancers in men and 14 of the 20 most common cancers. common cancers in men. Ladies.
“The declines in lung cancer and melanoma death rates are the result of advances across the cancer continuum — from reduced smoking rates to prevent cancer to discoveries such as targeted drug therapies and immune checkpoint inhibitors,” said Karen E. Knudsen, MBA, Ph. .D., CEO of American Cancer Society, who celebrated the progress.
RELATED: Simple blood test that can detect 50 types of cancer is now accurate enough to roll out
An analysis of long-term trends in cancer death rates in this year’s report also shows that death rates improved in both men and women from 2001 to 2018. In men, a decline of 1.8% per year in 2001-2015 improved to 2.3% per year during 2015-2018. Among women, cancer rates fell by 1.4% per year from 2001-2015 and fell even more in 2015-2018 at a rate of 2.1%. The report found that overall cancer death rates in 2014-2018 also declined in every racial and ethnic group.
“The continued decline in the cancer death rate should be gratifying to the cancer research community, as evidence that scientific advances over several decades are making a real difference in population-level outcomes,” said Norman Sharpless, MD, director of the National Cancer Institute, part of the National Institutes of Health.
CHECKING OUT: Doctor can determine perfect prescriptions for stage 4 cancer and his results are ‘stunning’
The authors also reported that cancer death rates continued to decline in children under 15 and also in young adults aged 15-39, despite an increase in incidence rates from 2001 to 2017.
Another positive finding was found in liver cancer incidence rates, which were previously increasing but have stabilized in both men and women.
“I believe we can achieve even further improvements if we tackle obesity, which has the potential to overtake tobacco use to become the main modifiable factor associated with cancer,” Sharpless added.
The annual report is a collaborative effort of the American Cancer Society (ACS); the Centers for Disease Control and Prevention (CDC); the National Cancer Institute (NCI), part of the National Institutes of Health; and the North American Association of Central Cancer Registries (NAACCR).
SHARE this excellent good news with friends on social media…